Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Ethamsylate (250mg) Tablet
Dosage Form : Tablet
Packaging Type : Alu Strip
Packaging : 10*10
Price : ₹81.75/-
Etastyle 250 Tablet contains Ethamsylate (250mg), a hemostatic agent used to control and prevent excessive bleeding. Ethamsylate works by stabilizing capillary walls, improving blood clotting, and preventing blood vessel leakage. This action helps to reduce bleeding episodes caused by a variety of conditions. It is particularly effective in treating heavy menstrual bleeding (menorrhagia), nosebleeds (epistaxis), and preventing excessive bleeding during and after surgical procedures.
Ethamsylate is known for its ability to strengthen the walls of small blood vessels (capillaries), which makes it a useful treatment in conditions involving capillary fragility. The drug also promotes platelet aggregation, which is essential for proper clotting and helps reduce blood loss in individuals with conditions that involve abnormal bleeding or clotting.
Etastyle 250 Tablet is commonly used in gynecology to manage abnormal uterine bleeding, in surgical patients to reduce post-operative bleeding, and in patients with bleeding disorders. It can also be beneficial in preventing gastrointestinal bleeding in certain conditions.
Common side effects may include mild nausea, dizziness, headache, and skin rash. Rarely, allergic reactions or gastrointestinal discomfort may occur.
Etastyle 250 Tablet is indicated for the prevention and treatment of excessive bleeding in conditions such as menorrhagia, epistaxis, and post-surgical bleeding.
Consult a healthcare provider before use if pregnant, breastfeeding, or using anticoagulant medications.
Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Bromfenac (0.09% w/v) + Moxifloxacin (0.5% w/v)
Composition : Bromfenac (0.9mg) Eye Drops
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Loteprednol etabonate (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation